Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 17, 2011, discussed and decide that the members of the Company will consider to the approve the below mentioned Special and Ordinary Resolution by way of Postal Ballot.1. To consider and approve the alteration, amendment, variation and revision of site pertaining to the proposed project mentioned in the prospectus dated August 22, 2011.... Board Meeting on Dec 17, 2011
Brooks Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 17, 2011, inter alia, to discuss and decide the following business:1. To consider and approve the alternation, amendment, variation and revision of site pertaining to the proposed project mentioned in the prospectus dated August 22, 2011.2. To shift the registered office of the Company, from one state to another state. Company receives approval for manufacture of Doripenem Monohydrate Injection from DGHS
Brooks Laboratories Ltd has informed BSE that the Company has received approval for manufacture of Doripenem Monohydrate Injection from Directorate General of Health Service. The Company is all set to manufacture this drug within this fiscal year.Doripenem is a broad spectrum anti-bacterial agent of carbapenem family. Growing bacterial resistance is major cause of concern for researchers as it contributors to increase in mortality, morbidity... Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that the Board of Directors in their meeting held on November 19, 2011, pursuant to the provisions of Section 295 of the Companies Act, 1956 and subject to the approval of the Central Government, sanction the proposal of making a loan of the maximum amount of Rs. 30000000/- (Three Crores only) each to Mr. Atul Ranchal, Chairman cum whole time director and Mr. Rajesh Mahajan, Managing Director of the Company. Board Meeting on Nov 19, 2011
Brooks Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 19, 2011, inter alia, to discuss and decide regarding the loan to Mr. Rajesh Mahajan, Managing director and Mr. Atul Ranchal, Whole time director of the Company under Section 295 of the Companies Act, 1956. Financial Results for Sep 30, 2011
Brooks Laboratories Ltd has informed BSE about the Financial Results for the period ended September 30, 2011. Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 17, 2011, has discussed and decided the following matters.1. Board decided to avail the facility of Buyer's Credit.2. Board discussed and approved the Payment of minimum bonus required under Payment of Bonus Act, 1965.3. Board discusses and authorized Mr. Atul Ranchal & Mr. Rajesh Mahajan for Purchasing land in Gujarat. Outcome of Board Meeting
Brooks Laboratories Ltd has informed BSE that the Board of Directors of the Company at it meeting held on September 19, 2011, inter alia, discussed and decided the following;1. Board appoints Dr. D. S. Maity as Chief Executive Officer of the Company w.e.f. September 19, 2011.2. Board appoints Mr. Ketan Shah as Chief Financial Officer of the Company w.e.f. September 19, 2011.3. Board approved the draft and adopts the code of conducts of the Company.